Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MiSight 1 Day Safety Post-Approval Study

NCT: NCT05285527 · ACTIVE_NOT_RECRUITING

NCT IDNCT05285527
StatusACTIVE_NOT_RECRUITING
Start Date2022-08-15
Completion2030-06-30
SponsorCooperVision, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this post-approval study is to confirm the safety of daily disposable soft contact lens wear among the intended patient population for the MiSight 1 Day lens in the US.

Frequently Asked Questions

What is MiSight 1 Day Safety Post-Approval Study?

MiSight 1 Day Safety Post-Approval Study is a clinical trial registered under NCT05285527. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05285527?

The current status of NCT05285527 (MiSight 1 Day Safety Post-Approval Study) is: ACTIVE_NOT_RECRUITING.

When did MiSight 1 Day Safety Post-Approval Study start?

MiSight 1 Day Safety Post-Approval Study started on 2022-08-15.

Related Devices

K181920Clariti 1 day (somofilcon A) Soft (Hydrophilic) Daily Disposable Contact Lens with UV BlockerCooperVision, Inc. K234127Clariti 1 day Multifocal (somofilcon A) Soft (Hydrophilic), Daily Disposable Contact Lens with UV BlockerCooperVision, Inc. K220070MyDay (stenfilcon A) Soft (Hydrophilic) Daily Disposable Contact Lens, Avaira Vitality (fanfilcon A) Soft (Hydrophilic) Contact LensCooperVision, Inc. PMA P180035Daily wear soft contact lens to reduce the progression of myopiaCooperVision, Inc. K160803Avaira Vitality (fanfilcon A) Soft (Hydrofilic) Contact LensCooperVision, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑